tenk.fyi

Passage BIO, Inc.

PASGNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$45.5M

29.7% YoY

EPS

$-14.35

31.8% YoY

Cash

$46.3M

23.2% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade